Premalignant and malignant prostate lesions: Pathologic review

Cancer Control

Volumn 17, Issue 4, 2010, Pages 214-222

  Dickinson, Shohreh Iravani ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; CHROMOGRANIN A; PROSTATE SPECIFIC ANTIGEN;

ACINAR CELL; ADENOID CYSTIC CARCINOMA; ARTICLE; BASAL CELL CARCINOMA; BONE METASTASIS; CANCER RISK; CELL PROLIFERATION; CELL TYPE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; MALE; NEEDLE BIOPSY; NEUROENDOCRINE TUMOR; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RISK ASSESSMENT; SIGNET RING CARCINOMA; SQUAMOUS CELL CARCINOMA; UROGENITAL TRACT CANCER;

EID: 77958541477     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327481001700402     Document Type: Article

References (64)

1. Eldefrawy A, Katkoori D, De Los Santos R, et al. Basal cell carcinoma of the prostate: a case report and review of the literature. UroToday Int J. 2009;2(3).
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-249.
3. Begnami MD, Quezado M, Pinto P, et al. Adenoid cystic/basal cell carcinoma of the prostate: review and update. Arch Pathol Lab Med. 2007; 131(4):637-640.
4. Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int. 2002;90(2):162-173.
5. Chang JM, Lee HJ, Lee SE, et al. Pictorial review: unusual tumours involving the prostate: radiological-pathological findings. Br J Radiol. 2008; 81(971):907-915.
6. McNeal JE. Origin and development of carcinoma in the prostate. Cancer. 1969;23:24-34.
7. Dhom G. Unusual prostatic carcinomas. Pathol Res Pract. 1990; 186(1):28-36.
8. Grignon DJ. Unusual subtypes of prostate cancer. Mod Pathol. 2004; 17(3):316-327.
9. Umar SA, Umar SA, MacLenna GT. Small cell carcinoma of the prostate. J Urol. 2009;181(2):838-839.
10. Anker CJ, Dechet C, Isaac JC, et al. Small-cell carcinoma of the prostate. J Clin Oncol. 2008;26(7):1168-1171.
11. Palmgren JS, Karavadia SS, Wakefield MR. Unusual and underappreciated: small cell carcinoma of the prostate. Semin Oncol. 2007;34(1): 22-29.
12. Berruti A, Mosca A, Porpiglia F, et al. Chromogranin A expression in patients with hormone naïve prostate cancer predicts the development of hormone refractory disease. J Urol. 2007;178(3 pt 1):838-843; quiz 1129.
13. Wang W, Epstein JI. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases. Am J Surg Pathol. 2008; 32(1):65-71.
14. Trotz C. Prostate cancer with a normal PSA: small cell carcinoma of the prostate - a rare entity. J Am Board Fam Pract. 2003;16(4):343-344.
15. Yao JL, Madeb R, Bourne P, et al. Small cell carcinoma of the prostate: an immunohistochemical study. Am J Surg Pathol. 2006;30(6):705-712.
16. Mazzucchelli R, Lopez-Beltran A, Cheng L, et al. Rare and unusual histological variants of prostatic carcinoma: clinical significance. BJU Int. 2008;102(10):1369-1374.
17. Yao JL, Huang J, di Sant Agnese PA. Small cell carcinoma of the prostate. Diagn Histopathol. 2008;14:117-121.
18. Ayyathurai R, Civantos F, Soloway MS, et al. Basal cell carcinoma of the prostate: current concepts. BJU Int. 2007;99(6):1345-1349.
19. Segawa N, Tsuji M, Nishida T, et al. Basal cell carcinoma of the prostate: report of a case and review of the published reports. Int J Urol. 2008;15(6):557-559.
20. Halat SK, MacLennan GT. Adenoid cystic/basal cell carcinoma of the prostate. J Urol. 2008;179(4):1576.
21. Ali TZ, Epstein JI. Basal cell carcinoma of the prostate: a clinicopathologic study of 29 cases. Am J Surg Pathol. 2007;31(5):697-705.
22. Hudson E, Rashid M, Carter AC, et al. Basaloid carcinoma of the prostate: a case report and review of the literature. Eur J Cancer Care (Engl). 2008;17(5):509-511.
23. McKenney JK, Amin MB, Srigley JR, et al. Basal cell proliferations of the prostate other than usual basal cell hyperplasia: a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification. Am J Surg Pathol. 2004;28(10):1289-1298.
24. Iczkowski KA, Montironi R. Adenoid cystic/basal cell carcinoma of the prostate strongly expresses HER-2/neu. J Clin Pathol. 2006;59(12): 1327-1330.
25. Mohan H, Bal A, Punia RP, et al. Squamous cell carcinoma of the prostate. Int J Urol. 2003;10(2):114-116.
26. Palou J, Baniel J, Klotz L, et al. Urothelial carcinoma of the prostate. Urology. 2007;69(1 Suppl):50-61.
27. Njinou Ngninkeu B, Lorge F, Moulin P, et al. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. J Urol. 2003;169(1):149-152.
28. Rogers CG, Parwani A, Tekes A, et al. Carcinosarcoma of the prostate with urothelial and squamous components. J Urol. 2005;173(2): 439-440.
29. Lopez-Beltran A, Cheng L, Prieto R, et al. Lymphoepithelioma-like carcinoma of the prostate. Hum Pathol. 2009;40(7):982-987.
30. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol. 1986;17:64-71.
31. Epstein JI, Allsbrook WC Jr, Amin MB, et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29(9):1228-1242.
32. Putzi MJ, De Marzo AM. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology. 2000;56(5):828-832.
33. Bostwick DG, Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol. 2004;17(3):360-379.
34. Joniau S, Goeman L, Pennings J, et al. Prostatic intraepithelial neoplasia (PIN): importance and clinical management. Eur Urol. 2005;48(3): 379-385.
35. Cerveira N, Ribeiro FR, Peixoto A, et al. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. Neoplasia. 2006;8(10):826-832.
36. Perner S, Mosquera JM, Demichelis F, et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol. 2007;31(6):882-888.
37. Mackinnon AC, Yan BC, Joseph LJ, et al. Molecular biology underlying the clinical heterogeneity of prostate cancer: an update. Arch Pathol Lab Med. 2009;133(7):1033-1040.
38. Lotan TL, Toubaji A, Albadine R, et al. TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas. Mod Pathol. 2009; 22(3):359-365.
39. Ayala AG, Ro JY. Prostatic intraepithelial neoplasia: recent advances. Arch Pathol Lab Med. 2007;131(8):1257-1266.
40. Epstein JI, Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol. 2006;175(3 pt 1):820-834.
41. Melissari M, Lopez Beltran A, Mazzucchelli R, et al. High grade prostatic intraepithelial neoplasia with squamous differentiation. J Clin Pathol. 2006;59(4):437-439.
42. Tavora F, Epstein JI. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases. Am J Surg Pathol. 2008;32(7):1060-1067.
43. Godoy G, Taneja SS. Contemporary clinical management of isolated high-grade rostatic intraepithelial neoplasia. Prostate Cancer Prostatic Dis. 2008;11(1):20-31.
44. Tan PH, Tan HW, Tan Y, et al. Is high-grade prostatic intraepithelial neoplasia on needle biopsy different in an Asian population: a clinicopathologic study performed in Singapore. Urology. 2006;68(4):800-803.
45. Bishara T, Ramnani DM, Epstein JI. High-grade prostatic intraepithelial neoplasia on needle biopsy: risk of cancer on repeat biopsy related to number of involved cores and morphologic pattern. Am J Surg Pathol. 2004;28(5):629-633.
46. Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance. Mod Pathol. 2006;19 (12):1528-1535.
47. Kronz JD, Allan CH, Shaikh AA, et al. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy. Am J Surg Pathol. 2001; 25(8):1079-1085.
48. Abdel-Khalek M, El-Baz M, Ibrahiem el-H. Predictors of prostate cancer on extended biopsy in patients with high-grade prostatic intraepithelial neoplasia: a multivariate analysis model. BJU Int. 2004;94(4):528-533.
49. Netto GJ, Epstein JI. Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma. Am J Surg Pathol. 2006;30(9):1184-1188.
50. Akhavan A, Keith JD, Bastacky SI, et al. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy. BJU Int. 2007;99(4):765-769.
51. Godoy G, Taneja SS. Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia. Prostate Cancer Prostatic Dis. 2008;11(1):20-31.
52. Schoenfield L, Jones JS, Zippe CD, et al. The incidence of highgrade prostatic ntraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. BJU Int. 2007;99(4):770-774.
53. Herawi M, Kahane H, Cavallo C, et al. Risk of prostate cancer on first re-biopsy within 1 year following a diagnosis of high grade prostatic intraepithelial neoplasia is related to the number of cores sampled. J Urol. 2006;175(1):121-124.
54. Naya Y, Ayala AG, Tamboli P, et al. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy? Urology. 2004;63(3):503-508.
55. Girasole CR, Cookson MS, Putzi MJ, et al. Significance of atypical and suspicious small acinar proliferations, and high grade prostatic intraepithelial neoplasia on prostate biopsy: implications for cancer detection and biopsy strategy. J Urol. 2006;175(3 pt 1):929-33; discussion 933.
56. Meyer F, Têtu B, Bairati I, et al. Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer. Can J Urol. 2006;13(5): 3255-3260.
57. Wu CL, Yang XJ, Tretiakova M, et al. Analysis of alpha-methylacyl- CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Hum Pathol. 2004;35(8):1008-1013.
58. Stewart J, Fleshner N, Cole H, et al. Prognostic significance of alphamethylacyl- coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies. J Urol. 2008;179(5):1751-1755; discussion 1755.
59. Morote J, Fernández S, Alaña L, et al. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy. Clin Cancer Res. 2008;14(9):2617-2622.
60. Bostwick DG, Meiers I. Atypical small acinar proliferation in the prostate: clinical significance in 2006. Arch Pathol Lab Med. 2006;130(7): 952-957.
61. Leite KR, Camara-Lopes LH, Cury J, et al. Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy. Clinics (Sao Paulo). 2008;63(3):339-342.
62. Montironi R, Scattoni V, Mazzucchelli R, et al. Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy"). Eur Urol. 2006;50(4):666-674.
63. Epstein JI, Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol. 2006;175(3 pt 1):820-834.
64. Mallén E, Gil P, Sancho C, Jesús Gil M, et al. Atypical small acinar proliferation: review of a series of 64 patients. Scand J Urol Nephrol. 2006; 40(4):272-275.